TP53 and brain neoplasm: Since poor differentiation is an important hallmark of cancer cells, the manipulation of p53 for redirecting neural differentiation could emerge as a low toxicity alternative, in comparison with the conventionally used therapies, to sensitize brain tumor cells to chemotherapy (Her et al., 2018).